Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia

被引:7
|
作者
Nandeesha, H. [1 ]
Eldhose, A. [1 ]
Dorairajan, L. N. [1 ]
Anandhi, B. [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem & Urol, Pondicherry, India
关键词
adiponectin; benign prostatic hyperplasia; C-reactive protein; iron; prostate-specific antigen; SERUM ADIPONECTIN; CANCER; TISSUE; RISK;
D O I
10.1111/and.12715
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Elevated iron, high-sensitivity C-reactive protein (CRP) and hypoadiponectinemia are known to initiate tumour development. There is paucity of data regarding the above-mentioned parameters and their relation with prostate size in benign prostatic hyperplasia (BPH). The present study was designed to assess the levels of iron, hs-CRP and adiponectin levels and their association with prostate size in BPH patients. A total of 37 BPH cases and 36 controls were enrolled in the study. Iron, hs-CRP and adiponectin were estimated in both the groups. Iron and hs-CRP were significantly increased and adiponectin was significantly reduced in BPH cases when compared with controls. Iron (r=.397, p=.015), hs-CRP (r=.341, p=.039) and adiponectin (r=-.464, p=.004) were significantly associated with prostate size in BPH cases. Multivariate linear regression analysis showed that iron acts as predictor of prostate size in BPH (R-2 = 0.395, beta = 0.526, p=.001). We conclude that iron and hs-CRP are elevated and adiponectin is reduced in BPH cases and associated with prostate size.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] High levels of high-sensitivity C-reactive protein and impaired autonomic activity in smokers
    Alyan, Omer
    Kacmaz, Fehmi
    Ozdemir, Ozcan
    Karahan, Zulkuf
    Taskesen, Tuncay
    Iyem, Hikmet
    Alan, Sait
    Karadede, Aziz
    Ilkay, Erdogan
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2008, 36 (06): : 368 - 375
  • [22] High-sensitivity C-reactive protein: Clinical importance
    Bassuk, SS
    Rifai, N
    Ridker, PM
    CURRENT PROBLEMS IN CARDIOLOGY, 2004, 29 (08) : 439 - 493
  • [23] High-sensitivity C-reactive protein methods examined
    Rothkrantz-Kos, S
    Schmitz, MPJ
    Bekers, O
    Menheere, PPCA
    van Dieijen-Visser, MP
    CLINICAL CHEMISTRY, 2002, 48 (02) : 359 - 362
  • [24] High-sensitivity C-reactive protein in an tiphospholipid syndrome
    Alexandrova, E. N.
    Novikov, A. A.
    Reshetnyak, Tm.
    Popkova, Tv
    Novikova, D. S.
    Denisov, L. N.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 452 - 452
  • [25] Physical Activity and High-Sensitivity C-Reactive Protein
    Eric P. Plaisance
    Peter W. Grandjean
    Sports Medicine, 2006, 36 : 443 - 458
  • [26] Physical activity and high-sensitivity C-reactive protein
    Plaisance, Eric P.
    Grandjean, Peter W.
    SPORTS MEDICINE, 2006, 36 (05) : 443 - 458
  • [27] Elevated high-sensitivity C-reactive protein in preterm infants with pulmonary colonization with Ureaplasma
    Meadows, John T., Jr.
    Kopp, Benjamin T.
    Shook, Lori A.
    Ballard, Hubert O.
    Hayes, Don, Jr.
    JOURNAL OF THORACIC DISEASE, 2013, 5 (03) : 223 - 227
  • [28] High-Sensitivity C-Reactive Protein and Cardiovascular Disease
    Young, Ian
    Rifai, Nader
    CLINICAL CHEMISTRY, 2009, 55 (02) : 201 - 202
  • [29] Treatment concentration of high-sensitivity C-reactive protein
    Michos, Erin D.
    Blumenthal, Roger S.
    LANCET, 2018, 391 (10118): : 287 - 289
  • [30] A Test in Context High-Sensitivity C-Reactive Protein
    Ridker, Paul M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (06) : 712 - +